KIMS investor presentation: Q2 FY27 revenue up 41%, PAT up 5%
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Smallcap 250 and 1.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
KIMS filed an investor presentation on unaudited Q2 and H1 FY27 results. Q2 revenue rose 41.3% YoY to Rs 13,630 mn and EBITDA 34% to Rs 2,789 mn, but margin eased to 20.5% from 21.6%. PAT rose 5.1% to Rs 757 mn. H1 revenue grew 38.8% to Rs 25,589 mn, while PAT fell 28% to Rs 1,131 mn. Occupancy was 54.3% as newer hospitals ramped up.
Strong revenue growth and improving new-unit economics support the stock, but softer margins and a 28% fall in H1 PAT temper the outlook.